[1]郭银吉 孙永红.卵圆孔未闭与偏头痛相关性研究性进展[J].心血管病学进展,2025,(2):124.[doi:10.16806/j.cnki.issn.1004-3934.2025.02.007]
　GUO Yinji,SUN Yonghong.Research Progress of Patent Foramen Ovale and Migraine[J].Advances in Cardiovascular Diseases,2025,(2):124.[doi:10.16806/j.cnki.issn.1004-3934.2025.02.007]
点击复制

卵圆孔未闭与偏头痛相关性研究性进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2025年2期
页码:
124
栏目:
综述
出版日期:
2025-02-25

文章信息/Info

Title:
Research Progress of Patent Foramen Ovale and Migraine
作者:
郭银吉1 孙永红2
(1.甘肃中医药大学第一临床医学院,甘肃 兰州 730000;2.甘肃省人民医院儿科,甘肃 兰州 730000)
Author(s):
GUO Yinji 1; SUN Yonghong 2
(1.First Clinical Medical School,Gansu University of Chinese,Lanzhou 730000, Gansu,China;2.Department of Pediatrics,Gansu Provincial Peoples Hospital,Lanzhou 730000, Gansu,China)
关键词:
卵圆孔未闭; 偏头痛; 右向左分流; 卵圆孔未闭封堵术
Keywords:
Patent foramen ovale; Migraine; Right-to-left shunt; Closure of patent foramen ovale
DOI:
10.16806/j.cnki.issn.1004-3934.2025.02.007
摘要:
偏头痛是一种复杂的神经系统疾病,因其高患病率、严重致残和相当大的经济成本而给个人和社会带来巨大负担。大量研究报告称,卵圆孔未闭在有偏头痛的患者中更为普遍,而有先兆偏头痛患者的卵圆孔未闭发病率更高,但具体病理生理机制尚不明确。经导管卵圆孔未闭封堵术虽然已经在临床大量应用,但其改善偏头痛症状的作用仍存争议。现主要围绕卵圆孔未闭与偏头痛相关关系的研究进展进行综述。
Abstract:
Migraine is a complex neurological disease with high prevalence,severe disability and considerable economic cost,which imposes a huge burden on individuals and society. A number of studies have reported that patent foramen ovale is more common in patients with migraine,and the incidence of patent foramen ovale is higher in patients with migraine with aura,but the specific pathophysiological mechanism is not clear. Although the transcatheter closure of patent foramen ovale has been widely used in clinical practice,it is still controversial to improve the symptoms of migraine. This article will focus on the research progress on the relationship between patent foramen ovale and migraine

参考文献/References:

[1]万林姗,宋秀娟,刘燕燕,等. 偏头痛与卵圆孔未闭的研究进展[J]. 中国现代医学杂志,2023,33(10):48-54.

[2]Gupta J,Gaurkar SS. Migraine:an underestimated neurological condition affecting billions[J]. Cureus,2022,14(8):e28347.

[3]Eigenbrodt AK,Ashina H,Khan S,et al. Diagnosis and management of migraine in ten steps[J]. Nat Rev Neurol,2021,17(8):501-514.

[4]Ha H,Gonzalez A. Migraine headache prophylaxis[J].?Am Fam Physician,2019,99(1):17-24.

[5]Giblett JP,Williams LK,Kyranis S,et al. Patent foramen ovale closure:state of the art[J]. Interv Cardiol,2020,15:e15.

[6] Romano V,Gallinoro CM,Mottola R,et al. Patent foramen ovale—A not so innocuous septal atrial defect in adults[J]. J Cardiovasc Dev Dis,2021,8(6):60.

[6]Teshome M K,Najib K,Nwagbara C C,et al. Patent foramen ovale:a comprehensive review[J]. Current problems in cardiology,2020,45(2):100392.

[7]胡运洁,于筠琛,李永兴,等. 卵圆孔未闭与偏头痛相关性的研究进展[J]. 心肺血管病杂志,2021,40(8):882-884.

[8]McKenzie JA,Edwards WD,Hagler DJ. Anatomy of the patent foramen ovale for the interventionalist[J]. Catheter Cardiovasc Interv,2009,73(6):821-826.

[9]张玉顺,蒋世良,朱鲜阳. 卵圆孔未闭相关卒中预防中国专家指南[J]. 心脏杂志,2021,33(1):1-10.

[10]Vizzari G,Pizzino F,Zwicke D,et al. Patent foramen ovale:anatomical complexity and long-tunnel morphology related issues[J]. Am J Cardiovasc Dis,2021,11(3):316-329.

[11]吴艳,童飞,陈小武,等. 超声心动图联合超声右心声学造影对偏头痛患者卵圆孔未闭诊断价值探讨[J]. 中华保健医学杂志,2024,26(3):364-366.

[12]GBD 2016 Headache Collaborators. Global,regional,and national burden of migraine and tension-type headache,1990—2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol,2018,17(11):954-976.

[13]Safiri S,Pourfathi H,Eagan A,et al. Global,regional,and national burden of migraine in 204 countries and territories,1990 to 2019[J]. Pain,2022,163(2):e293-e309.

[14]del Sette M,Angeli S,Leandri M,et al. Migraine with aura and right-to-left shunt on transcranial Doppler:a case-control study[J]. Cerebrovasc Dis,1998,8(6):327-330.

[15]Shi F,Sha L,Li H,et al. Recent progress in patent foramen ovale and related neurological diseases:a narrative review[J]. Front Neurol ,2023,14:1129062.

[16]Tang Y,Peng A,Peng B,et al. Association between patent foramen ovale and migraine without aura:a community-based cross-sectional study in China[J]. BMJ Open,2022,12(3):e056937.

[17]He Q,Zhang Y,Wang F,et al. Impact of right-to-left shunt and transcatheter closure on the clinical features of migraine[J]. Int J Neurosci,2020,130(3):270-275.

[18]Tong Q,Yao Y,Xia Y,et al. The influence of patent foramen ovale on the clinical features of migraine without aura:a cross-sectional study[J]. Int J Gen Med,2023,16:3645-3654.

[19]Ashina M,Hansen JM,Do TP,et al. Migraine and the trigeminovascular system—40 years and counting[J]. Lancet Neurol,2019,18(8):795-804.

[20]Cao W,Shen Y,Zhong J,et al. The patent foramen ovale and migraine:associated mechanisms and perspectives from MRI evidence[J]. Brain Sci,2022,12(7):941.

[21]Mathew AA,Panonnummal R. Cortical spreading depression:culprits and mechanisms[J]. Exp Brain Res,2022,240(3):733-749.

[22]Nozari A,Dilekoz E,Sukhotinsky I,et al. Microemboli may link spreading depression,migraine aura,and patent foramen ovale[J]. Ann Neurol,2010,67(2):221-229.

[23]Li C,Yu Y,Li N,et al. Calcitonin gene-related peptide:a possible biomarker in migraine patients with patent foramen ovale[J]. BMC Neurol,2024,24(1):126.

[24]Katalinic D,Vcev A,Smolic M,et al. Serotonin receptor agonists in the treatment of migraine:a meta-analysis considering possible connection with paresthesia[J]. Ann Indian Acad Neurol,2022,25(3):332-333.

[25]Tanaka M,T?r?k N,Vécsei L. Are 5-HT1 receptor agonists effective anti-migraine drugs?[J]. Expert Opin Pharmacother,2021,22(10):1221-1225.

[26]Belyaeva II,Subbotina AG,Eremenko II,et al. Pharmacogenetics in primary headache disorders[J]. Front Pharmacol,2022,12:820214.

[27]Onan D,Younis S,Wellsgatnik WD,et al. Debate:differences and similarities between tension-type headache and migraine[J]. J Headache Pain,2023,24(1):92.

[28]Romano V,Gallinoro CM,Mottola R,et al. Patent foramen ovale—A not so innocuous septal atrial defect in adults[J]. J Cardiovasc Dev Dis ,2021,8(6):60.

[29]Szczygio? D,Motta E,Go?ba A,et al. Frequency of the C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene in patients with migraine with or without aura—A preliminary report[J]. Neurol Neurochir Pol,2012,46(5):443-449.

[30]Guo ZN,Qu Y,Gao Y,et al. Changes in cerebral autoregulation,stroke-related blood biomarkers,and autonomic regulation after patent foramen ovale closure in severe migraine patients[J]. CNS Neurosci Ther,2023,29(10):3031-3042.

[31]Kutty S,Sengupta PP,Khandheria BK,et al. Patent foramen ovale:the known and the to be known[J]. J Am Coll Cardiol,2012,59(19):1665-1671.

[32]Zhang Y,Wang H,Liu L. Patent foramen ovale closure for treating migraine:a meta-analysis[J]. J Interv Cardiol,2022,2022:6456272.

[33]Schwerzmann M,Wiher S,Nedeltchev K,et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks[J]. Neurology,2004,62(8):1399-1401.

[34]Dowson A,Mullen MJ,Peatfield R,et al. Migraine intervention with STARFlex technology (MIST) trial :a prospective,multicenter,double-blind,sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache[J]. Circulation,2008,117(11):1397-1404.

[35]Tobis J,Shenoda M. Percutaneous treatment of patent foramen ovale and atrial septal defects[J]. J Am Coll Cardiol,2012,60(18):1722-1732.

[36]Mattle HP,Evers S,Hildick-Smith D,et al. Percutaneous closure of patent foramen ovale in migraine with aura,a randomized controlled trial[J]. Eur Heart J,2016,37(26):2029-2036.

[37]Tobis JM,Charles A,Silberstein SD,et al. Percutaneous closure of patent foramen ovale in patients with migraine:the PREMIUM trial[J]. J Am Coll Cardiol,2017,70(22):2766-2774.

[38]Mas JL,Guillon B,Charles-Nelson A,et al. Patent foramen ovale closure in stroke patients with migraine in the CLOSE trial. The CLOSE-MIG study[J]. Eur J Neurol,2021,28(8):2700-2707.

[39]Turc G,Calvet D,Guérin P,et al. Closure,anticoagulation,or antiplatelet therapy for cryptogenic stroke with patent foramen ovale:systematic review of randomized trials,sequential meta-analysis,and new insights from the CLOSE study[J]. J Am Heart Assoc,2018,7(12):e008356.

[40]Zhang QQ,Lu JJ,Yan MY,et al. The efficacy of percutaneous patent foramen ovale closure on migraine:a meta-analysis of randomized controlled trials and observational studies[J]. Biomed Res Int,2021,2021:6643266.

相似文献/References:

[1]田晓光 陈武 徐琨 刘晓芳.经胸超声心动图声学造影与对比增强经颅多普勒对卵圆孔未闭右向左分流的筛查价值[J].心血管病学进展,2022,(4):371.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.020]
　TIAN Xiaoguang,CHEN WuXU Kun,LIU Xiaofang.The Screening Value of Contrast Transthoracic Echocardiography and Contrast-Enhanced Transcranial Doppler in the Right to Left Shunt of Patent Foramen Ovale[J].Advances in Cardiovascular Diseases,2022,(2):371.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.020]
[2]刘瑶 张丽娟 雍永宏 孙海建.斜卧呼吸-直立性低氧血症综合征机制与诊疗研究进展[J].心血管病学进展,2023,(8):752.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.018]
　LIU Yao,ZHANG Lijuan,YONG Yonghong,et al.Progress on the Mechanism,Diagnosis and Treatment of Platypnea-Orthodeoxia Syndrome[J].Advances in Cardiovascular Diseases,2023,(2):752.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.018]
[3]杜康 张育大 陈玺全 刘盼 杨颖.卵圆孔未闭相关疾病及封堵术研究进展[J].心血管病学进展,2025,(1):55.[doi:10.16806/j.cnki.issn.1004-3934.2025.01.013]
　DU Kang,ZHANG Yuda,CHEN Xiquan,et al.Diseases Related to Patent Foramen Ovale and Its Closure[J].Advances in Cardiovascular Diseases,2025,(2):55.[doi:10.16806/j.cnki.issn.1004-3934.2025.01.013]
[4]王华 陈科宇 秦永文 白元.新型卵圆孔未闭封堵器的研制及临床应用进展[J].心血管病学进展,2023,(9):781.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.004]
　WANG Hua,CHEN Keyu,QIN Yongwen,et al.Design and Clinical Practice of Novel Patent Foramen Ovale Occluders[J].Advances in Cardiovascular Diseases,2023,(2):781.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.004]

更新日期/Last Update: 2025-03-11